FDA Approved: RISEDRONATE SODIUM — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd)

View source ↗

Summary

FDA approved the generic drug risedronate sodium under an Original Application, expanding access to this bisphosphonate for osteoporosis- and Paget disease-rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Osteoporosis in Men
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

ORIG AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)